JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Small, A.
Right arrow Articles by Cafruny, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Small, A.
Right arrow Articles by Cafruny, E. J.
Journal of Pharmacology And Experimental Therapeutics, Vol. 156, Issue 3, 616-621, 1967
Copyright © 1967 by American Society for Pharmacology and Experimental Therapeutics


FUROSEMIDE AND HYDROCHLOROTHIAZIDE DO NOT HAVE A COMMON MODE OF ACTION

Alfred Small 1 and Edward J. Cafruny 1

1 Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota

The purpose of this study was to find out whether hydrochlorothiazide (HCTZ) and the more efficacious diuretic, furosemide, have a common mode of action (i.e., react with the same renal receptors) or have separate and distinctive modes of action. This was accomplished through use of Ex 4877, a competitive antagonist of the diuretic action of HCTZ. The antagonist did not modify diuretic response to furosemide in anesthetized dogs even though response to HCTZ was completely blocked. The possibility that furosemide had a much greater affinity for and could displace Ex 4877 from renal receptors was excluded by the finding that the action of HCTZ was still blocked in dogs that had responded fully to furosemide. These results might be explained by postulating that the two diuretics act at different tubular segments of the nephron, but this possibility is remote, for most published data indicate that their sites of action overlap. The most tenable conclusion is that furosemide has its own distinctive mode of action.

Submitted on October 19, 1966
Accepted on January 9, 1967







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics.